Cantargia AB is a biotechnology company headquartered in Lund, Sweden. It specializes in developing antibody-based treatments for cancer and autoimmune diseases.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Cantargia →Already a subscriber? Sign in
Xcout Intel tracks Cantargia continuously — this profile deepens as new filings, funding, people and hiring data arrive.